Lau, J., Bloch, P., Schffer, L., Pettersson, I., Spetzler, J., Kofoed, J., Madsen, K., Knudsen, L.B., McGuire, J., Steensgaard, D.B., Strauss, H.M., Gram, D.X., Knudsen, S.M., Nielsen, F.S., Thygesen, P., Reedtz-Runge, S., and Kruse, T., (2015), Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide, Journal of Medicinal Chemistry 58, 7370-7380
GLP-1
This is where medications like semaglutide may provide meaningful benefit
Protein shakes and supplements help bridge the gap between intake capacity and protein needs
This includes people living with obesity and type 2 diabetes, individuals who already have cardiovascular disease, and those at increased risk of developing kidney complications
It is therefore set up for excellent long-term growth, if it can relax pricing and find enough people willing to endure its symptoms